Allstate Corporation’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $10.9M | Buy |
22,006
+483
| +2% | +$214K | 0.11% | 107 |
|
|
2026
Q1 | $9.61M | Buy |
21,523
+2,428
| +13% | +$1.13M | 0.1% | 114 |
|
|
2025
Q4 | $8.66M | Buy |
19,095
+9,803
| +105% | +$4.23M | 0.12% | 113 |
|
|
2025
Q3 | $3.64M | Buy |
+9,292
| New | +$3.88M | 0.08% | 132 |
|
|
2025
Q2 | – | Sell |
-7,487
| Closed | -$3.63M | – | 550 |
|
|
2025
Q1 | $3.63M | Sell |
7,487
-128
| -2% | -$59.6K | 0.11% | 119 |
|
|
2024
Q4 | $3.07M | Buy |
+7,615
| New | +$3.53M | 0.09% | 125 |
|
|
2024
Q3 | – | Sell |
-906
| Closed | -$425K | – | 223 |
|
|
2024
Q2 | $425K | Sell |
906
-19
| -2% | -$8.25K | 0.03% | 136 |
|
|
2024
Q1 | $387K | Sell |
925
-6
| -0.6% | -$2.54K | 0.03% | 141 |
|
|
2023
Q4 | $379K | Sell |
931
-58
| -6% | -$21.4K | 0.03% | 132 |
|
|
2023
Q3 | $344K | Hold |
989
| – | – | 0.02% | 140 |
|
|
2023
Q2 | $348K | Buy |
989
+6
| +0.6% | +$2.02K | 0.02% | 144 |
|
|
2023
Q1 | $310K | Sell |
983
-11,653
| -92% | -$3.5M | 0.02% | 147 |
|
|
2022
Q4 | $3.65M | Hold |
12,636
| – | – | 0.11% | 128 |
|
|
2022
Q3 | $3.66M | Hold |
12,636
| – | – | 0.11% | 118 |
|
|
2022
Q2 | $3.56M | Sell |
12,636
-6,238
| -33% | -$1.67M | 0.11% | 120 |
|
|
2022
Q1 | $4.93M | Sell |
18,874
-208
| -1% | -$49.4K | 0.13% | 114 |
|
|
2021
Q4 | $4.19M | Buy |
19,082
+12,315
| +182% | +$2.39M | 0.08% | 194 |
|
|
2021
Q3 | $1.23M | Sell |
6,767
-387
| -5% | -$75.6K | 0.05% | 243 |
|
|
2021
Q2 | $1.44M | Sell |
7,154
-1,392
| -16% | -$291K | 0.05% | 211 |
|
|
2021
Q1 | $1.84M | Buy |
8,546
+2,111
| +33% | +$464K | 0.06% | 174 |
|
|
2020
Q4 | $1.52M | Sell |
6,435
-1,368
| -18% | -$314K | 0.05% | 192 |
|
|
2020
Q3 | $2.12M | Sell |
7,803
-1,715
| -18% | -$473K | 0.07% | 88 |
|
|
2020
Q2 | $2.76M | Buy |
9,518
+257
| +3% | +$69.7K | 0.09% | 81 |
|
|
2020
Q1 | $2.2M | Sell |
9,261
-21,700
| -70% | -$4.98M | 0.09% | 97 |
|
|
2019
Q4 | $6.78M | Buy |
30,961
+174
| +0.6% | +$35.2K | 0.12% | 94 |
|
|
2019
Q3 | $5.22M | Buy |
30,787
+1,961
| +7% | +$347K | 0.09% | 129 |
|
|
2019
Q2 | $5.29M | Buy |
28,826
+3,863
| +15% | +$675K | 0.09% | 119 |
|
|
2019
Q1 | $4.59M | Hold |
24,963
| – | – | 0.12% | 116 |
|
|
2018
Q4 | $4.14M | Buy |
+24,963
| New | +$4.33M | 0.14% | 113 |
|
Other funds holding VRTX
Allstate Corporation's VRTX Position: Q2 2026 in Review
Allstate Corporation increased its Vertex Pharmaceuticals (VRTX) stake by 2.2% in Q2 2026, buying an estimated $214K and bringing the position to 22,006 shares worth $10.9M. The position accounts for 0.11% of the portfolio, ranked #107.
Allstate Corporation first reported a position in VRTX in Q4 2018 and has held it in 29 quarters since. 1,761 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.
- Allstate Corporation held 22,006 shares of Vertex Pharmaceuticals worth $10.9M as of Q2 2026.
- Allstate Corporation bought 483 Vertex Pharmaceuticals shares in Q2 2026, an estimated $214K.
- Vertex Pharmaceuticals made up 0.11% of Allstate Corporation's portfolio in Q2 2026, its #107 holding.
- Allstate Corporation first reported a position in Vertex Pharmaceuticals in Q4 2018 and has held it in 29 quarters since.
- 1,761 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.
Based on Allstate Corporation's 13F filing for Q2 2026, filed 13 Aug 2026.